Search results

From Proteopedia

You searched for Immunotherapeutic

Jump to: navigation, search

There is no page with the exact title "Immunotherapeutic". The search results for "Immunotherapeutic" are displayed below. You can create a page titled Immunotherapeutic (by clicking on the red link).

For more information about searching Proteopedia, see Help.

To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.

Showing below up to 20 results starting with #1.


View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)

Article title matches

  1. Category:Immunotherapeutic agent (54 bytes)
    1: List of pages with the keyword Immunotherapeutic agent
  2. Category:Immunotherapeutic (48 bytes)
    1: List of pages with the keyword Immunotherapeutic

Page text matches

  1. 3w2d (4,019 bytes)
    14: ...lizing antibodies have been shown to be effective immunotherapeutic agents against this toxin, but the structural bas...
  2. 2wa0 (4,417 bytes)
    23: ...active target for the development of targeted and immunotherapeutic cancer treatments. Some MAGE proteins are thought...
  3. 2vwd (5,126 bytes)
    24: ... for these viruses has enabled the development of immunotherapeutic reagents which prevent virus attachment and subse...
  4. 8eoo (6,190 bytes)
    14: ...cination or natural infection, has provided vital immunotherapeutic options for curbing the COVID-19 pandemic and has...
  5. 2qhr (4,234 bytes)
    23: ...or humanization and development of a postexposure immunotherapeutic.
  6. Category:Immunotherapeutic agent (54 bytes)
    1: List of pages with the keyword Immunotherapeutic agent
  7. 2jrv (3,744 bytes)
    13: Structural analysis of immunotherapeutic peptides for autoimmune Myasthenia gravis.,Jung H...
  8. 2jrw (3,759 bytes)
    13: Structural analysis of immunotherapeutic peptides for autoimmune Myasthenia gravis.,Jung H...
  9. 3c3v (4,014 bytes)
    24: ...city of food allergens and for the development of immunotherapeutic agents. Previously, we have reported the crystall...
  10. 3csy (9,118 bytes)
    24: ...chanism of EBOV GP-mediated fusion and for future immunotherapeutic development.
  11. 3ft2 (14,035 bytes)
    26: ... the choice of tumor peptides for stem cell-based immunotherapeutic application.
  12. 3ft3 (5,847 bytes)
    25: ... the choice of tumor peptides for stem cell-based immunotherapeutic application.
  13. 3ft4 (5,829 bytes)
    25: ... the choice of tumor peptides for stem cell-based immunotherapeutic application.
  14. 3ifl (10,475 bytes)
    25: ...dy. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to ...
  15. 3ifn (10,476 bytes)
    25: ...dy. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to ...
  16. 3ifo (10,475 bytes)
    25: ...dy. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to ...
  17. 3ifp (10,476 bytes)
    25: ...dy. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to ...
  18. 3ujt (3,794 bytes)
    12: ...se results inform the development of vaccines and immunotherapeutic/immunoprophylactic antibodies against Ft by sugge...
  19. 3rtq (4,278 bytes)
    14: ...NKT) cells by CD1d-presented agonists is a potent immunotherapeutic tool. alpha-Galactosylceramide (alpha-GalCer) is ...
  20. 9dhy (5,275 bytes)
    14: The Coronavirus Immunotherapeutic Consortium (CoVIC) conducted side-by-side compari...

View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)



Search in namespaces:

Include only Seeded (Automatic) pages - only Human created pages
List redirects
Search for

You may also try
Views
Personal tools